 |
 |
 |
||
|
||||
 |
|
| Updated Sep. 1, 2010 |
|
||||||||
 |
|
 |
|
 |
|
 |
|
 |
|
||||||||
| |
|
Innovations in HIV Therapy
ISSUE: SEPTEMBER, 2007 Despite recent advances in HIV/AIDS therapy, issues such as universal drug availability, drug costs, and treatment infrastructure, as well as several important clinical issues, remain of significant concern. read more | |
|
AIDS Wasting Syndrome In the 21st Century
ISSUE: SEPTEMBER, 2007 Historically, wasting syndrome has been described in association with opportunistic infections and/or AIDSrelated malignancies.1 In 1987, the Centers for Disease Control and Prevention defined wasting syndrome as involuntary weight loss (of >10% from baseline) accompanied by chronic diarrhea, documented fever for more than 30 days, and asthenia. read more | |
|
HIV and Herpesvirus Infections
ISSUE: SEPTEMBER, 2007 As opportunistic infections, the human Herpesviridae play a significant role in the morbidity and mortality of individuals with HIV disease. read more | |
|
NEW! Combination Therapy in the Treatment of HIV—An Update
ISSUE: APRIL, 2007 Over the past 10 years, an impressive armamentarium of combination antiretrovirals (ARVs) has been developed, significantly improving the options available to manage HIV/AIDS. In all, 4 fixed-dose combinations (FDCs) and a 3-drug combination of tenofovir disoproxil fumarate, emtricitabine, and efavirenz—the first FDC, formed through the collaboration of multiple pharmaceutical industry partners, to achieve triple-drug combination ARV therapy in a single pill per day—have thus far received FDA approval. read more | |
|
Treatment Options For HIV
ISSUE: SEPTEMBER, 2006 Over the past year, the field of infectious diseases has marked both the 25th anniversary of the first reported cases of AIDS and the 10th anniversary of the beginning of the widespread use of potent combination antiretroviral therapy. read more | |
|
HIV and Herpesvirus Infections
ISSUE: SEPTEMBER, 2006 As opportunistic infections, the human Herpesviridae play a significant role in the morbidity and mortality of individuals with human to provide an updated reference on these diseases with recomimmunodeficiency virus (HIV) disease. read more | |
|
Commentary: The End of the Epidemic?
ISSUE: SEPTEMBER, 2006 HIV infection cannot be cured, and the virus is still being transmitted. However, the AIDS epidemic may already have ended. What can that possibly mean? read more | |
|
HIV and Herpesvirus Infections
ISSUE: SEPTEMBER, 2005 As opportunistic infections, the human Herpesviridae play a significant role in the morbidity and mortality of individuals with HIV. The Herpesviridae are ubiquitous DNA viruses; with the exception of herpes simplex virus-2 (HSV-2) and human herpesvirus-8 (HHV-8), the Herpesviridae are highly prevalent in the general population. read more |
| |
| MOREHIV-AIDS/STIS | |
| |
|
• |
Innovations in HIV Management... [9/2005] |
|
• |
Managing Opportunistic Infections In HIV Patients... [9/2004] |
|
• |
Innovations in HIV Therapy 2004... [9/2004] |
|
• |
Antiretroviral Resistance Testing: An Update for t... [9/2004] |
 HIV-AIDS/STIs Archives | |
| home | about us | advertise | contact | publications |